Michael R Ujhelyi

Michael R Ujhelyi,

Associate Dean, Orlando Campus

Department: Pharmacotherapy & Translational Research
Business Phone: (612) 325-0399
Business Email: mujhelyi@cop.ufl.edu

Teaching Profile

Courses Taught
2020
PHA5956 Special Topics/Self-Directed Study

Publications

2009
Spinal cord stimulation improves ventricular function and reduces ventricular arrhythmias in a canine postinfarction heart failure model.
Circulation. 120(4):286-94 [DOI] 10.1161/CIRCULATIONAHA.108.812412. [PMID] 19597055.
2008
A novel catheter system for totally implantable intravenous drug therapy: assessment of catheter function and patency with trepostinil therapy.
The journal of vascular access. 9(1):20-7 [PMID] 18379976.
2008
Baseline myocardial perfusion predicts response to cardiac resynchronization therapy: a prospective observational study.
Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing. 23(2):127-33 [DOI] 10.1007/s10840-008-9285-3. [PMID] 18686023.
2008
Pericardial delivery of omega-3 fatty acid: a novel approach to reducing myocardial infarct sizes and arrhythmias.
American journal of physiology. Heart and circulatory physiology. 294(5):H2212-8 [DOI] 10.1152/ajpheart.91502.2007. [PMID] 18326793.
2008
Scared to death.
Pharmacotherapy. 28(11):1311-4 [DOI] 10.1592/phco.28.11.1311. [PMID] 18956990.
2007
Interatrial conduction measured during biventricular pacemaker implantation accurately predicts optimal paced atrioventricular intervals.
Journal of cardiovascular electrophysiology. 18(3):290-5 [PMID] 17313655.
2006
Decreasing pain and anxiety associated with patient-activated atrial shock: a placebo-controlled study of adjunctive sedation with oral triazolam.
Journal of cardiovascular electrophysiology. 17(4):391-5 [PMID] 16643361.
2006
Focal pharmacological modulation of atrioventricular nodal conduction via implantable catheter: a novel therapy for atrial fibrillation?
Circulation. 113(20):2383-90 [PMID] 16702470.
2006
Utility of adjunctive single oral bolus propafenone therapy in patients with atrial defibrillators.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 8(3):211-5 [PMID] 16627442.
2005
Intrathecal clonidine reduces the incidence of ischemia-provoked ventricular arrhythmias in a canine postinfarction heart failure model.
Heart rhythm. 2(10):1122-7 [PMID] 16188594.
2005
Thoracic spinal cord stimulation reduces the risk of ischemic ventricular arrhythmias in a postinfarction heart failure canine model.
Circulation. 111(24):3217-20 [PMID] 15956128.
2005
Understanding atrial symptom reports: objective versus subjective predictors.
Pacing and clinical electrophysiology : PACE. 28(8):801-7 [PMID] 16105008.
2004
Better living through medical device technology.
Pharmacotherapy. 24(2):298-305; discussion 305 [PMID] 14998229.
2004
Do patients accept implantable atrial defibrillation therapy? Results from the Patient Atrial Shock Survey of Acceptance and Tolerance (PASSAT) Study.
Journal of cardiovascular electrophysiology. 15(3):286-91 [PMID] 15030417.
2004
Improving the acceptability of the atrial defibrillator: patient-activated cardioversion versus automatic night cardioversion with and without sedation (ADSAS 2).
Pacing and clinical electrophysiology : PACE. 27(7):910-7 [PMID] 15271009.
2004
Intrapericardial ibutilide administration fails to terminate pacing-induced sustained atrial fibrillation in dogs.
Cardiovascular drugs and therapy. 18(4):269-77 [PMID] 15367824.
2004
Nitrous oxide sedation reduces discomfort caused by atrial defibrillation shocks.
Pacing and clinical electrophysiology : PACE. 27(4):485-91 [PMID] 15078402.
2003
Electrical heterogeneity and arrhythmogenesis: importance of conduction velocity dispersion.
Journal of cardiovascular pharmacology. 41(5):795-803 [PMID] 12717112.
2003
Patient experiences with atrial fibrillation and treatment with implantable atrial defibrillation therapy.
Heart & lung : the journal of critical care. 32(5):291-9 [PMID] 14528186.
2003
Sleep quality among patients treated with implantable atrial defibrillation therapy: effect of nocturnal shock delivery and psychological distress.
Journal of cardiovascular electrophysiology. 14(9):960-4 [PMID] 12950541.
2002
Intrapericardial therapeutics: a pharmacodynamic and pharmacokinetic comparison between pericardial and intravenous procainamide delivery.
Journal of cardiovascular electrophysiology. 13(6):605-11 [PMID] 12108506.
2001
Defibrillation energy requirements and electrical heterogeneity during total body hypothermia.
Critical care medicine. 29(5):1006-11 [PMID] 11378613.
2001
Enhanced endothelin-1 response and receptor expression in small mesenteric arteries of insulin-resistant rats.
American journal of physiology. Heart and circulatory physiology. 280(2):H522-7 [PMID] 11158947.
2001
Lidocaine increases the proarrhythmic effects of monophasic but not biphasic shocks.
Journal of cardiovascular electrophysiology. 12(12):1363-8 [PMID] 11797993.
2000
Cytochrome P450 activity and endothelial dysfunction in insulin resistance.
Journal of vascular research. 37(5):426-34 [PMID] 11025406.
2000
Endotoxemia alters splanchnic capacitance.
Shock (Augusta, Ga.). 14(1):68-72 [PMID] 10909896.
2000
Metformin improves vascular function in insulin-resistant rats.
Hypertension (Dallas, Tex. : 1979). 35(1 Pt 1):108-12 [PMID] 10642283.
2000
Observations on the behavior of gibbons (Hylobates leucogenys, H. gabriellae, and H. lar) in the presence of mirrors.
Journal of comparative psychology (Washington, D.C. : 1983). 114(3):253-62 [PMID] 10994841.
2000
Regional hyperkalemia increases ventricular defibrillation energy requirements: role of electrical heterogeneity in defibrillation.
Journal of cardiovascular electrophysiology. 11(6):634-41 [PMID] 10868736.
1999
Action potentials that mimic fibrillation activate sodium current.
Journal of molecular and cellular cardiology. 31(9):1673-84 [PMID] 10471351.
1999
EDHF-mediated relaxation is impaired in fructose-fed rats.
Journal of cardiovascular pharmacology. 34(3):461-7 [PMID] 10471008.
1999
Impaired endothelium-mediated relaxation in coronary arteries from insulin-resistant rats.
Journal of vascular research. 36(5):385-92 [PMID] 10559679.
1999
Impaired vagal reflex activity in insulin-resistant rats.
Journal of cardiovascular pharmacology. 33(5):698-702 [PMID] 10226855.
1999
Induction of electrical heterogeneity impairs ventricular defibrillation: an effect specific to regional conduction velocity slowing.
Circulation. 100(25):2534-40 [PMID] 10604892.
1998
Disparate effects of biphasic and monophasic shocks on postshock refractory period dispersion.
The American journal of physiology. 274(6):H1943-9 [DOI] 10.1152/ajpheart.1998.274.6.H1943. [PMID] 9841521.
1998
Endothelial dysfunction precedes hypertension in diet-induced insulin resistance.
The American journal of physiology. 275(3):R788-92 [DOI] 10.1152/ajpregu.1998.275.3.R788. [PMID] 9728076.
1998
High-dose lidocaine does not affect defibrillation efficacy: implications for defibrillation mechanisms.
The American journal of physiology. 274(4):H1113-20 [DOI] 10.1152/ajpheart.1998.274.4.H1113. [PMID] 9575914.
1998
Lidocaine’s effect on defibrillation threshold are dependent on the defibrillation electrode system: epicardial versus endocardial.
Journal of cardiovascular electrophysiology. 9(3):312-20 [PMID] 9554736.
1997
Aging effects on the organic base transporter and stereoselective renal clearance.
Clinical pharmacology and therapeutics. 62(2):117-28 [PMID] 9284847.
1997
Hypertonic saline does not reverse the sodium channel blocking actions of lidocaine: evidence from electrophysiologic and defibrillation studies.
Journal of cardiovascular pharmacology. 29(1):61-8 [PMID] 9007672.
1997
Lidocaine does not affect myocardial electrical heterogeneity: implications for low proarrhythmic actions.
Pharmacotherapy. 17(6):1267-73 [PMID] 9399610.
1996
Influence of hypertonic saline solution infusion on defibrillation efficacy.
Chest. 110(3):784-90 [PMID] 8797427.
1996
Is there any intermediate stage between animal communication and language?
Journal of theoretical biology. 180(1):71-6 [PMID] 8763359.
1996
Mechanism of antiarrhythmic drug-induced changes in defibrillation threshold: role of potassium and sodium channel conductance.
Journal of the American College of Cardiology. 27(6):1534-42 [PMID] 8626970.
1996
Urine acidification affects the activity of the organic base transporter in a nonstereoselective manner.
The Journal of pharmacology and experimental therapeutics. 276(2):683-9 [PMID] 8632337.
1995
Differential effects of lidocaine on defibrillation threshold with monophasic versus biphasic shock waveforms.
Circulation. 92(6):1644-50 [PMID] 7664452.
1995
Lidocaine prophylaxis for fatal ventricular arrhythmias after acute myocardial infarction.
Clinical pharmacology and therapeutics. 57(4):471-8 [PMID] 7712677.
1995
Pharmacokinetic aspects of digoxin-specific Fab therapy in the management of digitalis toxicity.
Clinical pharmacokinetics. 28(6):483-93 [PMID] 7656506.
1993
Antifibrillatory and electrophysiologic actions of moricizine alone and in combination with lidocaine: a prospective, randomized trial.
Critical care medicine. 21(10):1577-84 [PMID] 8403970.
1993
Evaluation of the need to modify antiarrhythmic therapy because of drug intolerance or inefficacy in patients evaluated by electrophysiology study.
American heart journal. 126(2):352-9 [PMID] 8338006.
1993
Spotlight article: quinidine enhances digitalis toxicity at therapeutic serum digoxin levels. (Mordel A, Halkin H, Zulty I, Almog S, Ezra D. Clin Pharm Ther 1993;53:457-62).
Heart & lung : the journal of critical care. 22(6):560-2 [PMID] 8288462.
1993
The pharmacokinetic and pharmacodynamic interaction between propafenone and lidocaine.
Clinical pharmacology and therapeutics. 53(1):38-48 [PMID] 8422740.
1992
Defibrillation energy requirements during moricizine and moricizine-lidocaine therapy.
Journal of cardiovascular pharmacology. 20(6):932-9 [PMID] 1282596.
1992
Evaluation and comparison of the adverse effects of streptokinase and alteplase.
Pharmacotherapy. 12(6):440-4 [PMID] 1492007.
1991
Absorption of oral ciprofloxacin in a patient with cardiogenic shock.
Pharmacotherapy. 11(4):336-9 [PMID] 1923916.
1989
Angiotensin-converting enzyme inhibitors: mechanistic controversies.
Pharmacotherapy. 9(6):351-62 [PMID] 2559394.

Contact Details

Phones:
Business:
(612) 325-0399
Emails:
Addresses:
Business Mailing:
6550 SANGER RD
ORLANDO FL 32827